BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29698574)

  • 1. N-glycan signatures identified in tumor interstitial fluid and serum of breast cancer patients: association with tumor biology and clinical outcome.
    Terkelsen T; Haakensen VD; Saldova R; Gromov P; Hansen MK; Stöckmann H; Lingjaerde OC; Børresen-Dale AL; Papaleo E; Helland Å; Rudd PM; Gromova I
    Mol Oncol; 2018 Jun; 12(6):972-990. PubMed ID: 29698574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling of microRNAs in tumor interstitial fluid of breast tumors - a novel resource to identify biomarkers for prognostic classification and detection of cancer.
    Halvorsen AR; Helland Å; Gromov P; Wielenga VT; Talman MM; Brunner N; Sandhu V; Børresen-Dale AL; Gromova I; Haakensen VD
    Mol Oncol; 2017 Feb; 11(2):220-234. PubMed ID: 28145100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum N-glycan analysis in breast cancer patients--Relation to tumour biology and clinical outcome.
    Haakensen VD; Steinfeld I; Saldova R; Shehni AA; Kifer I; Naume B; Rudd PM; Børresen-Dale AL; Yakhini Z
    Mol Oncol; 2016 Jan; 10(1):59-72. PubMed ID: 26321095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring serum and immunoglobulin G N-glycome as diagnostic biomarkers for early detection of breast cancer in Ethiopian women.
    Gebrehiwot AG; Melka DS; Kassaye YM; Gemechu T; Lako W; Hinou H; Nishimura SI
    BMC Cancer; 2019 Jun; 19(1):588. PubMed ID: 31208374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput proteomics of breast cancer interstitial fluid: identification of tumor subtype-specific serologically relevant biomarkers.
    Terkelsen T; Pernemalm M; Gromov P; Børresen-Dale AL; Krogh A; Haakensen VD; Lethiö J; Papaleo E; Gromova I
    Mol Oncol; 2021 Feb; 15(2):429-461. PubMed ID: 33176066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Review: Immunoglobulin G
    Liu D; Li Q; Zhang X; Wang H; Cao W; Li D; Xing W; Song M; Wang W; Meng Q; Wang Y
    OMICS; 2019 Dec; 23(12):607-614. PubMed ID: 31414971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles.
    Kyselova Z; Mechref Y; Kang P; Goetz JA; Dobrolecki LE; Sledge GW; Schnaper L; Hickey RJ; Malkas LH; Novotny MV
    Clin Chem; 2008 Jul; 54(7):1166-75. PubMed ID: 18487288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-mannose glycans are elevated during breast cancer progression.
    de Leoz ML; Young LJ; An HJ; Kronewitter SR; Kim J; Miyamoto S; Borowsky AD; Chew HK; Lebrilla CB
    Mol Cell Proteomics; 2011 Jan; 10(1):M110.002717. PubMed ID: 21097542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the Tumor Secretome from Tumor Interstitial Fluid (TIF).
    Gromov P; Gromova I
    Methods Mol Biol; 2016; 1459():231-47. PubMed ID: 27665563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-glycan profiling of tissue samples to aid breast cancer subtyping.
    Benesova I; Nenutil R; Urminsky A; Lattova E; Uhrik L; Grell P; Kokas FZ; Halamkova J; Zdrahal Z; Vojtesek B; Novotny MV; Hernychova L
    Sci Rep; 2024 Jan; 14(1):320. PubMed ID: 38172220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine profiling of tumor interstitial fluid of the breast and its relationship with lymphocyte infiltration and clinicopathological characteristics.
    Espinoza JA; Jabeen S; Batra R; Papaleo E; Haakensen V; Timmermans Wielenga V; Møller Talman ML; Brunner N; Børresen-Dale AL; Gromov P; Helland Å; Kristensen VN; Gromova I
    Oncoimmunology; 2016; 5(12):e1248015. PubMed ID: 28123884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of protein clusters predictive of response to chemotherapy in breast cancer patients.
    Cortesi L; Barchetti A; De Matteis E; Rossi E; Della Casa L; Marcheselli L; Tazzioli G; Lazzaretti MG; Ficarra G; Federico M; Iannone A
    J Proteome Res; 2009 Nov; 8(11):4916-33. PubMed ID: 19739612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass spectrometric profiling reveals association of N-glycan patterns with epithelial ovarian cancer progression.
    Chen H; Deng Z; Huang C; Wu H; Zhao X; Li Y
    Tumour Biol; 2017 Jul; 39(7):1010428317716249. PubMed ID: 28681696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isomer-specific profiling of N-glycans derived from human serum for potential biomarker discovery in pancreatic cancer.
    Liu Y; Wang C; Wang R; Wu Y; Zhang L; Liu BF; Cheng L; Liu X
    J Proteomics; 2018 Jun; 181():160-169. PubMed ID: 29674015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum N-glycan profiles differ for various breast cancer subtypes.
    Vreeker GCM; Vangangelt KMH; Bladergroen MR; Nicolardi S; Mesker WE; Wuhrer M; van der Burgt YEM; Tollenaar RAEM
    Glycoconj J; 2021 Jun; 38(3):387-395. PubMed ID: 33877489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of serum N-glycan profiling as a diagnostic and prognostic biomarker in germ-cell tumors.
    Narita T; Hatakeyama S; Yoneyama T; Narita S; Yamashita S; Mitsuzuka K; Sakurai T; Kawamura S; Tochigi T; Takahashi I; Nakaji S; Tobisawa Y; Yamamoto H; Koie T; Tsuchiya N; Habuchi T; Arai Y; Ohyama C
    Cancer Med; 2017 Apr; 6(4):739-748. PubMed ID: 28317343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulated proteins in the fluid bathing the tumour cell microenvironment as potential serological markers for early detection of cancer of the breast.
    Gromov P; Gromova I; Bunkenborg J; Cabezon T; Moreira JM; Timmermans-Wielenga V; Roepstorff P; Rank F; Celis JE
    Mol Oncol; 2010 Feb; 4(1):65-89. PubMed ID: 20005186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery.
    Celis JE; Gromov P; Cabezón T; Moreira JM; Ambartsumian N; Sandelin K; Rank F; Gromova I
    Mol Cell Proteomics; 2004 Apr; 3(4):327-44. PubMed ID: 14754989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive N-Glycome Profiling of Cells and Tissues for Breast Cancer Diagnosis.
    Li Q; Li G; Zhou Y; Zhang X; Sun M; Jiang H; Yu G
    J Proteome Res; 2019 Jun; 18(6):2559-2570. PubMed ID: 30889355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of N-glycosylation with breast carcinoma and systemic features using high-resolution quantitative UPLC.
    Saldova R; Asadi Shehni A; Haakensen VD; Steinfeld I; Hilliard M; Kifer I; Helland A; Yakhini Z; Børresen-Dale AL; Rudd PM
    J Proteome Res; 2014 May; 13(5):2314-27. PubMed ID: 24669823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.